Archive of Rosa's World-Wide Webinars: Impact of Modeling and Simulation in Drug Development
Sign in for free videos, downloads, or slides of past Webinars here (Each session lasts about 1 hour)
- April 17, 2012. Using mathematical models to set design criteria for antibody-based therapies
- Dr. Birgit Schoeberl; Vice President of Discovery; Merrimack Pharmaceuticals
- March 20, 2012. Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions
- Joga Gobburu, PhD FCP MBA; School of Pharmacy|School of Medicine, Univ. of Maryland, Baltimore
- February 13, 2012. PK/PD-based Development of Anti-infective Agents
- Hartmut Derendorf, PhD; University of Florida, Gainesville
- December 13, 2011. Translational Modeling & Simulation in Support of Rational Drug Discovery: Principles, Challenges and Examples
- Tristan Maurer, PharmD, PhD; Research Fellow at Pfizer Pharmaceuticals
- November 14, 2011. Moving PK/PD From Basic Towards Systems Pharmacology
- William J. Jusko, PhD, SUNY (Buffalo)
- October 17, 2011. Developing Models that are Fit for Purpose — A Model Qualification Method
- Christina Friedrich, PhD, Rosa & Co
- September 19, 2011. Clinical Pharmacology = Disease Progression + Drug Action
- Nick Holford, MBChB, University of Auckland, New Zealand
- July 26, 2011. Standards and Software in Biomedical Systems Modeling
- Herbert Sauro, PhD, University of Washington, Seattle.
- June 20, 2011. How to build a PhysioPD model
- Rebecca Baillie, PhD, Rosa & Co
- May 24, 2011. Overview of modeling tools in drug development
- Rada Savic, PhD, Uppsala University
- April 18, 2011. Learn & Apply Paradigm in Drug Development: How disease-drug-trial models can aid decisions
- Joga Gobburu, PhD, Division of Parmacometrics, OCP/FDA